NextGen
Since 2011
Russia
Central Federal District of the Russian Federation
Moscow
143026, territory Skolkovo of the innovation center, Bolshoy Boulevard, 42 building 1, floor 1 of room 334 slave to month 51
Owners
By Nekstgen (Russia) – it is founded in November, 2011, the main field of activity of the company – implementation of researches, developments and their implementation in the field of gene therapy, development of methods of treatment of diseases using gennoterapevtichesky medicines and a method of therapeutic angiogenesis, development of methods of prevention and treatment of hereditary diseases and also pathologies from a genetic component. Prodazhy and distribution of gennoterapevtichesky medicines, including medicine for treatment of ischemia of the lower extremities Neovaskulgen, is engaged the daughter Nekstgen, Nekstgen Pharm LLC company[1].
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |